Arcturus Therapeutics (ARCT) News Today $21.20 +0.73 (+3.57%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$20.82 -0.38 (-1.77%) As of 08:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock ARCT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Public Employees Retirement System of Ohio Makes New Investment in Arcturus Therapeutics Holdings Inc. $ARCTOctober 7 at 3:12 AM | marketbeat.comArcturus Therapeutics (NASDAQ:ARCT) Shares Down 4.7% - Should You Sell?October 6 at 7:07 PM | marketbeat.comArcturus Therapeutics (NASDAQ:ARCT) Shares Gap Up - Here's What HappenedOctober 1, 2025 | marketbeat.comArcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 9.7% - Here's What HappenedSeptember 29, 2025 | marketbeat.comArcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 7.4% - Should You Buy?September 26, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of "Buy" from AnalystsSeptember 26, 2025 | marketbeat.comCathie Wood’s ARK Sells Roku and Roblox, Buys Arcturus StockSeptember 25, 2025 | investing.comCathie Wood’s ARK Investment buys 28.3K shares of Arcturus Therapeutics todaySeptember 24, 2025 | msn.comArcturus Therapeutics Shows Progress Amid Transition: Why I Assign A Hold RatingSeptember 23, 2025 | seekingalpha.comGuggenheim Sticks to Its Buy Rating for Arcturus Therapeutics (ARCT)September 21, 2025 | theglobeandmail.comLeerink Partners Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)September 21, 2025 | theglobeandmail.comArcturus Therapeutics (NASDAQ:ARCT) Shares Up 5.4% - Here's WhySeptember 17, 2025 | marketbeat.comGoldman Sachs Group Inc. Acquires 42,636 Shares of Arcturus Therapeutics Holdings Inc. $ARCTSeptember 17, 2025 | marketbeat.comCathie Wood’s ARK Investment buys 27.4K shares of Arcturus Therapeutics todaySeptember 16, 2025 | msn.comInnovative Therapeutics Pipeline Positions Industry for Strong Market GrowthSeptember 15, 2025 | finance.yahoo.comDynamic Technology Lab Private Ltd Buys Shares of 28,257 Arcturus Therapeutics Holdings Inc. $ARCTSeptember 15, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. $ARCT Shares Sold by Woodline Partners LPSeptember 14, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Has $1.53 Million Stake in Arcturus Therapeutics Holdings Inc. $ARCTSeptember 13, 2025 | marketbeat.comBrokers Set Expectations for ARCT Q3 EarningsSeptember 9, 2025 | marketbeat.comInvesco Ltd. Boosts Stock Position in Arcturus Therapeutics Holdings Inc. $ARCTSeptember 8, 2025 | marketbeat.comHC Wainwright Initiates Coverage on Arcturus Therapeutics (NASDAQ:ARCT)September 6, 2025 | marketbeat.comNuveen LLC Purchases New Position in Arcturus Therapeutics Holdings Inc. $ARCTSeptember 6, 2025 | marketbeat.comArcturus Therapeutics assumed with a Buy at H.C. WainwrightSeptember 4, 2025 | msn.comForecasting The Future: 5 Analyst Projections For Arcturus TherapeuticsSeptember 4, 2025 | benzinga.comVestal Point Capital LP Invests $2.24 Million in Arcturus Therapeutics Holdings Inc. $ARCTSeptember 4, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Consensus Recommendation of "Buy" by AnalystsSeptember 2, 2025 | marketbeat.comVanguard Group Inc. Purchases 64,367 Shares of Arcturus Therapeutics Holdings Inc. $ARCTSeptember 1, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. $ARCT Shares Bought by AlphaQuest LLCAugust 30, 2025 | marketbeat.comArcturus Therapeutics to Attend Upcoming Investor ConferencesAugust 26, 2025 | mms.businesswire.comArcturus Therapeutics price target lowered to $54 from $63 at LeerinkAugust 22, 2025 | msn.comArcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 3.9% - Should You Sell?August 20, 2025 | marketbeat.comResearch Analysts Set Expectations for ARCT FY2025 EarningsAugust 16, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Estimate for ARCT EarningsAugust 16, 2025 | marketbeat.comQ3 EPS Estimate for Arcturus Therapeutics Lifted by AnalystAugust 16, 2025 | marketbeat.comArcturus Therapeutics (NASDAQ:ARCT) Trading 24.8% Higher - What's Next?August 15, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | msn.comWells Fargo & Company Has Lowered Expectations for Arcturus Therapeutics (NASDAQ:ARCT) Stock PriceAugust 13, 2025 | marketbeat.comWilliam Blair Reaffirms Their Buy Rating on Arcturus Therapeutics (ARCT)August 12, 2025 | theglobeandmail.comScotiabank Sticks to Its Buy Rating for Arcturus Therapeutics (ARCT)August 12, 2025 | theglobeandmail.comArcturus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)August 12, 2025 | benzinga.comArcturus Therapeutics Shares Climb on Loss, Revenue Beating Analyst ExpectationsAugust 12, 2025 | marketwatch.comArcturus Therapeutics price target raised to $49 from $47 at CitiAugust 12, 2025 | msn.comArcturus Therapeutics price target lowered to $42 from $45 at Wells FargoAugust 12, 2025 | msn.comArcturus Therapeutics (NASDAQ:ARCT) Posts Quarterly Earnings Results, Beats Expectations By $0.77 EPSAugust 12, 2025 | marketbeat.comArcturus Therapeutics shares edge higher despite earnings miss in Q2August 12, 2025 | uk.investing.comArcturus Therapeutics: Q2 Earnings SnapshotAugust 12, 2025 | sfgate.comArcturus outlines pivotal trial plans and advances CF and OTC programs with regulatory meetings expected in 2026August 12, 2025 | msn.comArcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline ProgressAugust 12, 2025 | finance.yahoo.comArcturus Therapeutics Holdings Inc. (ARCT) Q2 2025 Earnings Conference Call TranscriptAugust 11, 2025 | seekingalpha.comArcturus Therapeutics (NASDAQ:ARCT) Rating Increased to Hold at Wall Street ZenAugust 10, 2025 | marketbeat.com Get Arcturus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARCT Media Mentions By Week ARCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARCT News Sentiment▼1.010.63▲Average Medical News Sentiment ARCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARCT Articles This Week▼34▲ARCT Articles Average Week Get the Latest News and Ratings for ARCT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arcturus Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies IDEAYA Biosciences News Belite Bio News ImmunityBio News Arcutis Biotherapeutics News Recursion Pharmaceuticals News Mesoblast News Disc Medicine News Agios Pharmaceuticals News Denali Therapeutics News Sarepta Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARCT) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcturus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
